Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
ARUP Laboratories, |
RCV001001152 | SCV001158301 | benign | not specified | 2019-03-30 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV002068765 | SCV002351817 | likely benign | not provided | 2024-01-22 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV002497318 | SCV002813576 | likely benign | BLOOD GROUP--SWANN SYSTEM; BLOOD GROUP--WALDNER TYPE; BLOOD GROUP--FROESE; BLOOD GROUP--WRIGHT ANTIGEN; Southeast Asian ovalocytosis; Hereditary spherocytosis type 4; BLOOD GROUP--DIEGO SYSTEM; Cryohydrocytosis; Autosomal dominant distal renal tubular acidosis; Renal tubular acidosis, distal, 4, with hemolytic anemia; Malaria, susceptibility to | 2021-12-07 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV004553545 | SCV004793045 | likely benign | SLC4A1-related disorder | 2020-12-31 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |